Antileishmanial activity of 5-nitroindazole derivatives

Background: Currently, there is no safe and effective vaccine against leishmaniasis and existing therapies are inadequate due to high toxicity, cost and decreased efficacy caused by the emergence of resistant parasite strains. Some indazole derivatives have shown in vitro and in vivo activity agains...

Full description

Bibliographic Details
Main Authors: Niurka Mollineda-Diogo, Claudia Sissely Chaviano-Montes de Oca, Sergio Sifontes-Rodríguez, Teresa Espinosa-Buitrago, Lianet Monzote-Fidalgo, Alfredo Meneses-Marcel, Aliuska Morales-Helguera, Yunierkis Perez-Castillo, Vicente Arán-Redó
Format: Article
Language:English
Published: SAGE Publishing 2023-10-01
Series:Therapeutic Advances in Infectious Disease
Online Access:https://doi.org/10.1177/20499361231208294